Study summary

The purpose of this study is to evaluate the safety and efficacy of ASP015K in moderate to severe rheumatoid arthritis (RA) subjects

Additional Study Details

Phase
2
Product
  • peficitinib
  • Placebo
  • Type
    Interventional
    Masking
    Triple (Participant, Care Provider, Outcomes Assessor)
    Enrollment number
    289
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Rethy Pal Korhaz es Rendelointezet
      Bekescsaba, Hungary, 5600
      Completed
      Achieve Clinical Research, LLC
      Birmingham, AL, United States, 35216
      Completed
      Health Research of Oklahoma
      Oklahoma City, OK, United States, 73103
      Completed
      Cliditer S.A. de C.V.
      México, Distrito Federal, Mexico, 6700
      Completed
      Budai Irgalmasrendi Korhaz
      Budapest,, Hungary, 1027
      Completed
      NZOZ Centrum Medyczne ProMiMed
      Krakow, Poland, 31-637
      Completed
      MEDICAL PLUS, s.r.o. or REVMACENTRUM UH, s.r.o.
      Uherske Hradiste, Czech Republic, 68601
      Completed
      MHAT "Sv. Ivan Rilski"
      Sofia, Bulgaria, 1612
      Completed
      Arthritis Associates
      Orlando, FL, United States, 32804
      Completed
      Jacksonville Center for Clinical Research
      Jacksonville, FL, United States, 32216
      Completed
      Pacific Arthritis Center Medical Group
      Santa Maria, CA, United States, 93454
      Completed
      Stanford University School of Medicine
      Palo Alto, California, United States, 94304
      Completed
      Desert Medical Advances
      Palm Desert, CA, United States, 92260
      Completed
      Orszgos Reumatolgiai s Fizioterpis Intzet
      Budapest, Hungary, 1027
      Completed
      Kenezy Hospital Institute of Clinical Pharmacology
      Debrecen, Hungary, H-4043
      Completed
      Clincal Research Center of Reading
      Wyomissing, PA, United States, 19610
      Completed
      PV-MEDICAL s.r.o.
      Zlin, Czech Republic, 760 01
      Completed
      Zespol Poradni Specjalistycznych, REUMED sp. Zo.o
      Lublin, Poland, 20-582
      Completed
      The Center for Rheumatology and Bone Research
      Wheaton, MD, United States, 20902
      Completed
      PMG Research
      Hickory, NC, United States, 28602
      Completed
      Center for Arthritis and Osteoporosis
      Elizabethtown, KY, United States, 42701
      Completed
      Szpital Uniwersytecki nr. 2 im. Dr. Jana Biziela
      Bydgoszcz, Poland, 85-168
      Completed
      Mountain State Clinical Research
      Clarksburg, West Virginia, United States, 26301
      Completed
      Altoona Center for Clinical Research
      Duncansville, PA, United States, 16635
      Completed
      Revita Clinic Rheumatology
      Budapest, Hungary, 1027
      Completed
      Centro de Investigacion Clinica de Morelia, S.C.
      Morelia, Mexico, 58070
      Completed
      Revmatologicky ustav
      Praha 2, Czech Republic, 128 50
      Completed
      University of California San Diego
      LaJolla, CA, United States, 92093-0943
      Completed
      ARS Rheumatica
      Warszawa, Poland, 02-653
      Completed
      MHAT Plovdiv AD
      Plovdiv, Bulgaria, 4003
      Completed
      Revmatologicka ambulance
      Praha-Nusle, Czech Republic, 140 00
      Completed
      Deerbrook Medical Asssociates
      Vernon Hills, IL, United States, 60061
      Completed
      Arthritis Associates of Colorado Springs
      Colorado Springs, Colorado, United States, 80910
      Completed
      Dr Javier Orozco Alcala Private Doctor´s office
      Guadalajara, Mexico, 44650
      Completed
      Rheumatology Consultants, PLLC
      Knoxville, TN, United States, 37909-1907
      Completed
      Austin Rheumatology Research PA
      Austin, TX, United States, 78705
      Completed
      Illinois Bone & Joint Institute; LLC
      Morton Grove, IL, United States, 60053
      Completed
      MHAT Burgas
      Burgas, Bulgaria, 8000

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?